Complete response of extensive alopecia areata refractory to baricitinib after five months of treatment with upadacitinib

FI: 2,9
Type: Article

Home · Ee11-Immune-mediated Skin Diseases (Emerging)

Artículo original

Year: 2024

Brands

de la Torre-gomar, FJ; Velasco-Amador, JP; Prados-Carmona, A; Ruiz-Villaverde, R

Magazine

Title: JOURNAL OF DERMATOLOGICAL TREATMENT

Quartile

Q2